• Japanese
  • Korean
  • Chinese
Cover Image

China Animal Vaccine Industry Report, 2013-2016

Animal vaccine is a kind of biological agent that enables inoculated animals to produce active immunity for disease prevention. Europe and the United States and other developed countries are the main force of traditional animal vaccine markets in the world, still taking around 60% nowadays. In recent years, European and American animal vaccine markets have decelerated growth due to quality safety, high maturity and other factors, while the fast-growing animal vaccine market of China and other emerging countries will become a new highlight.

In 2004-2013, Chinese animal vaccine market size maintained a high growth rate of 26.3%, reaching about RMB11.5 billion in 2013. The growth in 2007-2010 was mainly driven by the expansion of governmental tender vaccine, while that from 2011 was primarily thanks to the market-oriented vaccine expansion. The Chinese animal vaccine market is basically occupied by local companies, showing a self-sufficiency rate of around 90%.

Given the policy factor, Chinese animal vaccine products are divided into compulsory immunization vaccines and market-oriented vaccines. At present, the former include foot-and-mouth disease (FMD), bird flu, porcine reproductive and respiratory syndrome (PRRS), swine fever, and peste des petits ruminants (PPR); the latter refer to porcine circovirus (PCV), Newcastle disease, porcine parvovirus (PPV) and other varieties. Since 2011, the bids for compulsory vaccines proposed by the Chinese government has turned to be more fierce, with limited growth potential; however, market-oriented vaccines have developed faster, enjoying 40%-50% market share in 2013.

According to animal attributes, animal vaccines can be classified into swine vaccines, poultry vaccines, cattle & sheep vaccines, pet vaccines and other vaccines. In 2013, Chinese swine vaccines and poultry vaccines accounted for more than 80% of the animal vaccine market. In addition, the emerging Chinese pet industry is boosting the demand for pet vaccines, but due to lack of commercialized pet vaccines, China now mainly relies on imports. Thus, the Chinese pet vaccine market will see a larger space for development in the future.

As the scale of Chinese farming escalates, the demand for animal vaccines will continue to grow steadily. In the next few years, the Chinese animal vaccine industry is expected to keep a growth rate of approximately 15% and see market value of RMB17.5 billion or so in 2016.

In 2006, China implemented mandatory veterinary drug GMP certification to raise the threshold, resulting in a sharp decline in the number of animal vaccine companies and the accompanying increased industry concentration. In 2013, CAHIC seized the highest market share of 10.5% among Chinese listed animal vaccine companies, followed by Jinyu Group, Tecon and Dahuanong with a combined proportion of 15% or so.

“China Animal Vaccine Industry Report, 2013-2016” by ResearchInChina covers the followings:

  • The market size, market structure and competitive landscape of the global animal vaccine industry;
  • The market size, market structure, competitive landscape and import & export of the Chinese animal vaccine industry;
  • Policies, social environment and downstream demand of the Chinese animal vaccine industry;
  • The size and competitive landscape of Chinese animal vaccine market segments such as swine vaccines and poultry vaccines;
  • Operation, animal vaccine business, forecast and outlook of 10 Chinese animal vaccine manufacturers;
  • The market size and market structure of Chinese animal vaccine market and its segments in 2013-2016E.

Table of Contents

1. Overview of Animal Vaccine

  • 1.1. Definition
  • 1.2. Classification
  • 1.3. Industry Chain

2. Status Quo of Animal Vaccine Industry

  • 2.1. Global Market
    • 2.1.1. Market Size
    • 2.1.2. Market Structure
    • 2.1.3. Competitive Landscape
    • 2.1.4. New Epidemics and Products
  • 2.2. Chinese Market
    • 2.2.1. Market Size
    • 2.2.2. Market Structure
    • 2.2.3. Import and Export
    • 2.2.4. Profit
    • 2.2.5. Entry Barriers
    • 2.2.6. Competitive Landscape
    • 2.2.7. Trends

3. Development Environment for China Animal Vaccine Industry

  • 3.1. Policy Environment
    • 3.1.1. Major Policies
    • 3.1.2. Tendering System for Compulsory Immunization Vaccine
  • 3.2. Social Environment
    • 3.2.1. Stable Development of Farming Industry
    • 3.2.2. Large-scale Farming Becomes a Trend
    • 3.2.3. Frequent Outbreaks of Animal Epidemics

4. Chinese Animal Vaccine Industry Segments

  • 4.1. Governmental Mandatory Vaccine
    • 4.1.1. FMD Vaccine
    • 4.1.2. Bird Flu Vaccine
    • 4.1.3. PRRS Vaccine
    • 4.1.4. Swine Fever Vaccine
  • 4.2. Market-oriented Vaccine
    • 4.2.1. PCV Vaccine
    • 4.2.2. Newcastle Disease Vaccine
  • 4.3. Pet Vaccine

5. Key Enterprises

  • 5.1. CAHIC
    • 5.1.1. Profile
    • 5.1.2. Operation
    • 5.1.3. Revenue Structure
    • 5.1.4. Gross Margin
    • 5.1.5. R & D
    • 5.1.6. Animal Vaccine Business
    • 5.1.7. Forecast and Outlook
  • 5.2. Jinyu Group
    • 5.2.1. Profile
    • 5.2.2. Operation
    • 5.2.3. Revenue Structure
    • 5.2.4. Gross Margin
    • 5.2.5. R & D
    • 5.2.6. Animal Vaccine Business
    • 5.2.7. Forecast and Outlook
  • 5.3. Tecon
    • 5.3.1. Profile
    • 5.3.2. Operation
    • 5.3.3. Revenue Structure
    • 5.3.4. Gross Margin
    • 5.3.5. R & D
    • 5.3.6. Clients and Suppliers
    • 5.3.7. Animal Vaccine Business
    • 5.3.8. Forecast and Outlook
  • 5.4. Tech-bank
    • 5.4.1. Profile
    • 5.4.2. Operation
    • 5.4.3. Revenue Structure
    • 5.4.4. Gross Margin
    • 5.4.5. R & D
    • 5.4.6. Animal Vaccine Business
    • 5.4.7. Forecast and Outlook
  • 5.5. Shenghua Biok
    • 5.5.1. Profile
    • 5.5.2. Operation
    • 5.5.3. Revenue Structure
    • 5.5.4. Gross Margin
    • 5.5.5. Clients
    • 5.5.6. Animal Vaccine Business
    • 5.5.7. Forecast and Outlook
  • 5.6. Ringpu Bio-technology
    • 5.6.1. Profile
    • 5.6.2. Operation
    • 5.6.3. Revenue Structure
    • 5.6.4. Gross Margin
    • 5.6.5. R & D
    • 5.6.6. Animal Vaccine Business
    • 5.6.7. Forecast and Outlook
  • 5.7. Dahuanong
    • 5.7.1. Profile
    • 5.7.2. Operation
    • 5.7.3. Revenue Structure
    • 5.7.4. Gross Margin
    • 5.7.5. R & D
    • 5.7.6. Animal Vaccine Business
    • 5.7.7. Forecast and Outlook
  • 5.8. Hile Bio
    • 5.8.1. Profile
    • 5.8.2. Operation
    • 5.8.3. Revenue Structure
    • 5.8.4. Gross Margin
    • 5.8.5. R & D
    • 5.8.6. Clients and Suppliers
    • 5.8.7. Animal Vaccine Business
    • 5.8.8. Forecast and Outlook
  • 5.9. Yikang
    • 5.9.1. Profile
    • 5.9.2. Operation
    • 5.9.3. Revenue Structure
    • 5.9.4. Gross Margin
    • 5.9.5. R & D
    • 5.9.6. Clients and Suppliers
    • 5.9.7. Animal Vaccine Business
  • 5.10. Chopper
    • 5.10.1. Profile
    • 5.10.2. Operation
    • 5.10.3. Revenue Structure
    • 5.10.4. Gross Margin
    • 5.10.5. R & D
    • 5.10.6. Clients and Suppliers
    • 5.10.7. Animal Vaccine Business

6. Summary and Forecast

  • 6.1. Summary
  • 6.2. Development Forecast
    • 6.2.1. Swine Vaccine
    • 6.2.2. Poultry Vaccine
    • 6.2.3. Cattle and Sheep Vaccine
    • 6.2.4. Pet Vaccine

Selected Charts:

  • Classification of Animal Health Products
  • Animal Vaccine Types (by Constituent and Feature) and Characteristics
  • Animal Vaccine Industry Chain
  • Classification of Animal Epidemics in China
  • Global Animal Vaccine Market Size, 2008-2016E
  • Profile of Global Animal Health Products Giants
  • Commercialized Vaccines and Manufacturers in Overseas Market in Recent Years
  • Development Process of Chinese Compulsory Vaccination Policies
  • Chinese Animal Vaccine Market Size, 2004-2013
  • China's Animal Vaccine Net Import Value and Dependence on Export, 2008-2013
  • China's Animal Vaccine Product Structure (by Animal Species), 2010-2013
  • China's Animal Vaccine Product Structure (by Vaccine Type), 2010-2013
  • China's Animal Vaccine Import and Export Volume, 2009-2014
  • China's Average Animal Vaccine Import and Export Prices, 2009-2014
  • China's Animal Vaccine Import Sources (by Import Volume), 2013
  • China's Animal Vaccine Export Destinations (by Export Volume), 2013
  • Main Regions Which Import Animal Vaccines and Their Share in Import Volume in China, 2013
  • Main Regions Which Export Animal Vaccines and Their Share in Export Volume in China, 2013
  • Gross Margin of Animal Vaccine Business of Major Listed Animal Vaccine Companies in China, 2011-2013
  • Barriers to Entry into Animal Vaccine Industry in China
  • Major Chinese Animal Vaccine Manufacturers and Their Capacity, 2013
  • Competitive Landscape of China Animal Vaccine Industry, 2013
  • Gap between Chinese Vaccine Production Process and International Advanced Level
  • Sino-foreign Joint Animal Vaccine Enterprises, 1990-2013
  • Major Polices on China Animal Vaccine Industry, 2010-2014
  • Compulsory Immunization Plan of Animal Epidemics in China, 2013
  • Animal Diseases worth Priority Prevention in China, 2013-2020
  • Defects of Compulsory Vaccination Tender System in China
  • Direction for Compulsory Vaccination Tender System Reform in China
  • Output of Meat, Eggs and Milk in China, 2009-2013
  • China's Meat Product Structure (by Output), 2011-2013
  • Farming Scale Degree in China, 2010-2020E
  • Overview of Common Animal Epidemics in China
  • Animal Epidemic Summary in China, 2013
  • China's Animal Vaccine Market Structure (by Sales Method)
  • Competitive Landscape of Main Compulsory Immunization Vaccine Markets in China, 2013
  • Performance Comparison between Swine Fever Vaccines in China
  • Classification and Market Conditions of Market-oriented Vaccines in China
  • Market Capacity of Some Compulsory Market-oriented Vaccines in China, 2013
  • Market Capacity of Some Non-compulsory Vaccines in China, 2013
  • Market Capacity of Newcastle Disease Vaccine and Market Share of Ringpu Bio-technology
  • Pet Vaccine Suppliers in Chinese Market and Their Products
  • CAHIC's Revenue and Net Income, 2009-2013
  • CAHIC's Revenue (by Product), 2011-2013
  • CAHIC's Revenue Structure (by Product), 2011-2013
  • CAHIC's Revenue (by Region), 2011-2013
  • CAHIC's Revenue Structure (by Region), 2011-2013
  • Gross Margin of CAHIC's Main Products, 2011-2013
  • CAHIC's R & D Costs and % of Total Revenue, 2011-2013
  • CAHIC's Animal Vaccine Subsidiaries and Their Products
  • CAHIC's Animal Vaccine Projects under Construction, 2014
  • CAHIC's Revenue and Net Income, 2012-2016E
  • Jinyu Group's Revenue and Net Income, 2009-2013
  • Jinyu Group's Revenue (by Product), 2011-2013
  • Jinyu Group's Revenue Structure (by Product), 2011-2013
  • Jinyu Group's Revenue (by Region), 2011-2013
  • Jinyu Group's Revenue Structure (by Region), 2011-2013
  • Gross Margin of Jinyu Group's Main Business, 2010-2013
  • Jinyu Group's R & D Costs and % of Total Revenue, 2011-2013
  • Animal Vaccine Subsidiaries of Jinyu Group, 2013
  • Revenue and Net Income of Spirit Jinyu, 2012-2013
  • Jinyu Group's Revenue and Net Income, 2012-2016E
  • Tecon's Revenue and Net Income, 2009-2013
  • Tecon's Revenue (by Product), 2011-2013
  • Tecon's Revenue Structure (by Product), 2011-2013
  • Tecon's Revenue (by Region), 2011-2013
  • Tecon's Revenue Structure (by Region), 2011-2013
  • Gross Margin of Tecon's Main Products, 2011-2013
  • Tecon's R & D Costs and % of Total Revenue, 2011-2013
  • Tecon's Revenue from Top 5 Clients and % of Total Revenue, 2011-2013
  • Name List and Revenue Contribution of Tecon's Top 5 Clients, 2013
  • Tecon's Procurement from Top 5 Suppliers and % of Total Procurement, 2011-2013
  • Name List and Procurement Contribution of Tecon's Top 5 Suppliers, 2013
  • Tecon's Animal Vaccine Production Bases and Capacity, 2013
  • Tecon's Revenue and Net Income, 2012-2016E
  • Tech-bank's Revenue and Net Income, 2009-2013
  • Tech-bank's Revenue (by Product), 2011-2013
  • Tech-bank's Revenue Structure (by Product), 2011-2013
  • Tech-bank's Revenue (by Region), 2011-2013
  • Tech-bank's Revenue Structure (by Region), 2011-2013
  • Tech-bank's Gross Margin of Main Products, 2011-2013
  • Tech-bank's R & D Costs and % of Total Revenue, 2011-2013
  • Revenue and Net Income of Chengdu TECBOND, 2010-2013
  • Tech-bank's Revenue and Net Income, 2012-2016E
  • Shenghua Biok's Revenue and Net Income, 2009-2013
  • Shenghua Biok's Revenue (by Product), 2011-2013
  • Shenghua Biok's Revenue Structure (by Product), 2011-2013
  • Shenghua Biok's Revenue (by Region), 2011-2013
  • Shenghua Biok's Revenue Structure (by Region), 2011-2013
  • Gross Margin of Shenghua Biok's Main Products, 2011-2013
  • Shenghua Biok's Revenue from Top 5 Clients and % of Total Revenue, 2011-2013
  • Name List and Revenue Contribution of Shenghua Biok's Top 5 Clients, 2013
  • Revenue and Net Income of Qingdao Yebio, 2009-2013
  • Shenghua Biok's Revenue and Net Income, 2012-2016E
  • Ringpu Bio-technology's Revenue and Net Income, 2009-2013
  • Ringpu Bio-technology's Revenue (by Product), 2011-2013
  • Ringpu Bio-technology's Revenue Structure (by Product), 2011-2013
  • Ringpu Bio-technology's Revenue (by Region), 2012-2013
  • Ringpu Bio-technology's Revenue Structure (by Region), 2012-2013
  • Ringpu Bio-technology's Gross Margin of Main Products, 2011-2013
  • Ringpu Bio-technology's R & D Costs and % of Total Revenue, 2011-2013
  • Ringpu Bio-technology's Animal Vaccine Output and Sales Volume (by Product), 2011-2013
  • Sales and Gross Margin of Ringpu Bio-technology's Animal Vaccines (by Product), 2013
  • Ringpu Bio-technology's Animal Vaccine Subsidiaries and Their Products, 2013
  • Revenue and Net Income of Ringpu Bio-technology's Animal Vaccine Subsidiaries, 2013
  • Ringpu Bio-technology's Animal Vaccine Projects under Construction, 2013
  • Ringpu Bio-technology's Revenue and Net Income, 2012-2016E
  • Dahuanong's Revenue and Net Income, 2009-2013
  • Dahuanong's Revenue Structure (by Product), 2011-2013
  • Dahuanong's Revenue Structure (by Product), 2011-2013
  • Dahuanong's Revenue (by Region), 2011-2013
  • Dahuanong's Revenue Structure (by Region), 2011-2013
  • Gross Margin of Dahuanong's Main Products, 2011-2013
  • Dahuanong's R & D Costs and % of Total Revenue, 2011-2013
  • Capacity of Dahuanong's Animal Vaccine Products, 2010-2013
  • Output, Sales Volume and Sales-output Ratio of Dahuanong's Veterinary Biologics, 2012-2013
  • Dahuanong's Revenue and Net Income, 2012-2016E
  • Hile Bio's Main Products
  • Hile Bio's Revenue and Net Income, 2011-2013
  • Hile Bio's Revenue Structure (by Product), 2011-2013
  • Hile Bio's Revenue Structure (by Product), 2011-2013
  • Hile Bio's Revenue (by Region), 2011-2013
  • Hile Bio's Revenue Structure (by Region), 2011-2013
  • Gross Margin of Hile Bio's Main Products, 2011-2013
  • Hile Bio's R & D Costs and % of Total Revenue, 2011-2013
  • Name List and Revenue Contribution of Hile Bio's Top 5 Clients, 2013
  • Hile Bio's Procurement from Top 5 Suppliers and % of Total Procurement, 2011-2013
  • Name List and Procurement Contribution of Hile Bio's Suppliers, 2013
  • Hile Bio's Revenue Structure (by Product), 2013
  • Hile Bio's Revenue Structure (by Sales Method), 2011-2013
  • Hile Bio's Swine Vaccine Capacity, Output and Sales Volume, 2011-2013
  • Selling Prices of Hile Bio's Main Products, 2011-2013
  • Hile Bio's Animal Vaccine Fundraising Projects, 2014
  • Hile Bio's Revenue and Net Income, 2012-2016E
  • Yikang's Revenue and Net Income, 2009-2011
  • Yikang's Revenue Structure (by Product), 2009-2011
  • Yikang's Revenue Structure (by Product), 2009-2011
  • Yikang's Revenue (by Region), 2009-2011
  • Yikang's Revenue Structure (by Region), 2009-2011
  • Gross Margin of Yikang's Main Products, 2009-2011
  • Yikang's R & D Costs and % of Total Revenue, 2009-2011
  • Yikang's Revenue from Top 5 Clients and % of Total Revenue, 2009-2011
  • Name List and Revenue Contribution of Yikang's Top 5 Clients, 2011
  • Yikang's Procurement from Top 5 Suppliers and % of Total Procurement, 2009-2011
  • Name List and Procurement Contribution of Yikang's Suppliers, 2011
  • Yikang's Animal Vaccine Production Lines, 2009-2011
  • Yikang's Capacity, Output and Capacity Utilization, 2009-2011
  • Yikang's Output, Sales Volume and Sales-output Ratio, 2009-2011
  • Average Selling Price of Yikang's Main Products, 2009-2011
  • Yikang's Revenue Structure (by Sales Method), 2009-2011
  • Chopper's Revenue and Net Income, 2009-2011
  • Chopper's Revenue (by Product), 2011-2013
  • Chopper's Revenue Structure (by Product), 2011-2013
  • Chopper's Revenue (by Region), 2011-2013
  • Chopper's Revenue Structure (by Region), 2011-2013
  • Sales of Chopper's Main Vaccine Products, 2011-2013
  • Chopper's R & D Costs and % of Total Revenue, 2011-2013
  • Chopper's Revenue from Top 5 Clients and % of Total Revenue, 2011-2013
  • Name List and Revenue Contribution of Chopper's Top 5 Clients, 2013
  • Chopper's Procurement from Top 5 Suppliers and % of Total Procurement, 2011-2013
  • Name List and Procurement Contribution of Chopper's Suppliers, 2013
  • Chopper's Products and Clients (by Sales Method)
  • Chopper's Sales Structure by Sales Method, 2011-2013
  • Sales of Chopper's Main Vaccine Products, 2011-2013
  • Chopper's Sales Structure by Main Vaccine Product, 2011-2013
  • Chopper's Vaccine Capacity, Output and Capacity Utilization, 2011-2013
  • Chopper's Vaccine Output, Sales Volume and Sales-output Ratio, 2011-2013
  • Average Selling Price of Chopper's Main Vaccine Products, 2011-2013
  • Chopper's Investment Plan, 2014
  • Animal Vaccine Revenue of Major Animal Vaccine Companies in China, 2011-2013
  • Chinese Animal Vaccine Market Size, 2012-2016E
  • Chinese Animal Vaccine Market Structure (by Animal Attributes), 2013 vs 2016E
  • Chinese Swine Vaccine Market Size, 2012-2016E
  • Chinese Poultry Vaccine Market Size, 2012-2016E
Show More
Pricing
Get Notified
Email me when related reports are published